CLEAR Outcomes study: For people with, or at high risk for, cardiovascular disease who are statin intolerant

Hunter Diabetes Centre/The AIM Centre, Level 1, 41 Llewellyn St, Merewether, NSW, 2291

The CLEAR Outcomes study is testing if an investigational medication reduces the risk of major cardiovascular events in participants with, or at high risk for, cardiovascular disease. The study will also look at how the medication may affect cholesterol levels and how safe it is.

The study lasts for 2–5 years, involving both visits to our centre and phone calls. Visits will be frequent in the initial phases, moving on to 3-monthly as the study progresses.

There will be a number of health checks during the study visits, including physical examination, check of vital signs, and blood, urine and pregnancy tests. Participation is completely voluntary, and study medication and tests will be provided at no cost.

Participants need to be over 18, have, or be at high risk for, cardiovascular disease, and be unable to tolerate statins.

Dr Claire Morbey, Principal Investigator
02 4963 2323

Download the participant information sheet (PDF 320 KB)